Locally Advanced Breast Cancer (LABC)
Also known as: Locally Advance Breast Cancer (LABC) / Locally Advanced Breast Cancer / Locally advanced breast cancer (disorder) / Malignant neoplasm of breast of unspecified site / Malignant neoplasm of breast / Malignant breast neoplasm / Breast cancer / Malignant neoplasm of breast (disorder) / Breast tumor malignant / Breast tumour malignant / Breast cancer NOS / Breast cancer stage unspecified
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB01217 | Anastrozole | A competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women. |
| DB01248 | Docetaxel | A taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer. |
| DB06374 | Elacestrant | An estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. |
| DB06205 | Hyaluronidase (human recombinant) | An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents. |
| DB04845 | Ixabepilone | A microtubule inhibitor administered in combination with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines. |
| DB09074 | Olaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. |
| DB06366 | Pertuzumab | An antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents. |
| DB11760 | Talazoparib | A poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer and HRR gene-mutated metastatic castration-resistant prostate cancer. |
| DB00072 | Trastuzumab | A monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. |